Advertisement

Topics

Companies Related to "Hemostasis in Sickle Cell Disease--Infancy to Adulthood" [Most Relevant Company Matches] - Page: 20 RSS

01:20 EDT 24th March 2019 | BioPortfolio

Here are the most relevant search results for "Hemostasis in Sickle Cell Disease--Infancy to Adulthood" found in our extensive corporate database of over 50,000 company records.

Showing "Hemostasis Sickle Cell Disease Infancy Adulthood" Companies 476–500 of 3,800+

Probably Relevant

Synthetic Genomics, Inc.

Synthetic Genomics, Inc., is a private biotechnology company harnessing the power of living cells — nature’s most efficient machines — to create transformative medicines and bio-based products. With an unmatched understanding of how DNA and RNA instruct the functions of life, we program cells for improved purpose and function. Our R&D competencies ...


Prolexys Pharmaceuticals, Inc.

Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company’s therapeutic focus is on cancer and cardiovascular indications where Prolexys has identified novel, druggable therapeutic targets. Small molecules that act at these targets have been identified and tested in cell and animal models of diseas...

DiscoveryBioMed, Inc.

DiscoveryBioMed, Inc. is a life sciences and biotechnology company that engages in R&D and services work in human cell engineering and production and human cell-based drug discovery. The company is located within The Innovation Depot facility in Birmingham, Alabama. Using physiologically relevant cell culture models preferably derived from normal and disea...


Genprex, Inc.

Genprex, Inc. is a clinical stage gene therapy company developing a new approach to treating cancer, based upon a novel proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer fighting genes ...

Neurotech Pharmaceuticals, Inc.

Neurotech is developing sight-saving therapeutics for the treatment of chronic retinal diseases. The Company's lead product candidate, NT-501, is currently in late-stage clinical development for advanced dry age-related macular degeneration (dry AMD) and retinitis pigmentosa (RP). The Company's portfolio of product candidates also includes treatments for wet AMD. All of Neurotech's development pro...

BioTime, Inc. and Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics, Inc. is a leading biotechnology company in the emerging field of regenerative medicine. The company’s proprietary, industry leading platforms are based on its pluripotent stem cell and dendritic cell immunotherapy technologies. Asterias is focused on developing therapies to treat conditions in several medical areas where ther...

AutekBio, Inc.

AutekBio, Inc. is a biotech firm headquartered in the Bay Area, US. It uses its proprietary, state-of-the-art technologies to service the international bio-pharmaceutical market, with its wholly owned operation division in Beijing to conduct contract research and contract manufacturing business. It is the first of its kind in China and uniquely positioned....

Nextera Communications

Nextera is a privately owned Norwegian biotech company. Our approach is to manipulate the disease at the initiation of the escalating immune cascade by identifying and subsequently targeting the principal causative agent. The core technology of the company is our phage display engine, which we apply in protein engineering and evolution of T cell receptors ...

Cohesion Technologies

Cohesion Technologies, Inc. (Cohesion) discovers, develops and commercializes innovative resorbable biodevices, adhesive technologies, and delivery systems in the fields of tissue repair and regeneration. Cohesion's first product, CoStasis® surgical hemostat (CoStasis), is a sprayable liquid hemostat for use as an adjunct to hemostasis in all surgical procedures, with the exception of neuro, opht...

Axonyx

Axonyx is a biopharmaceutical company focused on the acquisition and development of proprietary products and technologies for the treatment and diagnosis of Alzheimer's Disease and other memory-related cognitive disorders including prion diseases such as Mad Cow Disease. After completion of a Phase II Proof of Concept clinical study in October of 2001 for Phenserine, Axonyx's lead product for Alzh...

Copeland's Restaurants

The Al Copeland Foundation has been established in memory of a true New Orleans legend, founder of Popeye's Fried Chicken and Biscuits, humanitarian, and world renowned entrepreneur, whose life was cut short by a rare and aggressive form of cancer, Merkel Cell Carcinoma. The purpose of this organization is to carry on Al Copeland Sr.'s wishes to help others with this type of cancer, aid in researc...

Kolltan Pharmaceuticals, Inc.

Kolltan is a development-stage company advancing therapeutics that target well-defined and validated molecular mechanisms of disease in areas of critical clinical need. Kolltan is developing a new generation of monoclonal antibody oncology therapeutics based on recent, seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the D...

Stratatech Corporation

Stratatech Corp. is a privately-held regenerative medicine company focused on the development and commercialization of cell-based, tissue-engineered skin substitute products for therapeutic and research applications. These products are made using the company’s proprietary NIKS® cells – a human keratinocyte progenitor cell line that faithfully ...

Sigilon Therapeutics

Sigilon Therapeutics is creating a new class of living therapeutics to transform the lives of patients with a wide range of chronic diseases, including hemophilia, Type 1 diabetes and lysosomal storage disorders. Our proprietary platform is designed to restore healthy cell and organ function through the implantation of immune-shielded and specially enginee...

Datascope

Datascope Corp. manufactures proprietary products for clinical health care markets in interventional cardiology and radiology, anesthesiology, cardiovascular and vascular surgery, emergency medicine and critical care.Below is a summary of our four major product lines.Cardiac Assist We are the pioneer in intra-aortic balloon pump and catheter technology. The intra-aortic balloon system that we manu...

Quanterix Corporation Quanterix

Quanterix is a company that’s digitizing biomarker analysis to advance the science of precision health. The company’s digital health solution, Simoa, is changing the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. In doing so, Quanterix enables much earlier disease ...

CALIFORNIA CLINICAL THROMBOSIS CENTER

The CALIFORNIA CLINICAL THROMBOSIS CENTER is dedicated to the evaluation and management of patients with disorders of Thrombosis, Hemostasis and Vascular Medicine:AtherosclerosisHeart AttackStrokePulmonary EmbolismDeep Vein ThrombosisRecurrent MiscarriageRetinal Vascular ThrombosisUnexplained BleedingFamily History of Thrombosis or BleedingThe mission of the CALIFORNIA CLINICAL THROMBOSIS CENTER i...

Leinco Technologies Incorporated

Leinco Technologies is a leading biotechnology company specializing in the development and manufacture of monoclonal and polyclonal antibodies, secondary antibodies, growth factors and cytokines for use in basic and applied life science research. In addition, we provide custom development and contract manufacturing services with expertise ranging from newly engineered cell lines to large scale ant...

APDA – Greater St. Louis

Every day, APDA – Greater St. Louis provides the support, education, and research that will help everyone impacted by Parkinson’s disease live life to the fullest. Located in Chesterfield, MO, APDA – Greater St. Louis funds the APDA Center for Advanced Parkinson Disease Research at Washington University School of Medicine. The Greater St. Louis Ch...

VisionGate Inc.

VisionGate, Inc. is led by Dr. Alan Nelson, physicist, bioengineer and entrepreneur who developed the world’s first and only automated screening test to detect cervical cancer, marketed today as FocalPoint by Becton Dickinson. VisionGate produces the first automated 3D cell imaging platform, the Cell-CT, which computes high-resolution 3D biosignatures...

American Lung Association in Indiana

Beginning our second century, the American Lung Association is the leading organization working to prevent lung disease and promote lung health. Lung disease death rates continue to increase while other leading causes of death have declined. The American Lung Association funds vital research on the causes of and treatments for lung disease. With the generous support of the public, the American Lun...

Cell>Point

Cell>Point is a clinical-stage biopharmaceutical company developing universal molecular imaging agents and molecular therapeutics for the diagnosis, treatment and treatment monitoring of cancer, heart, and other diseases. Cell>Point has exclusive license to five drug-development platforms, all from The University of Texas M. D. Anderson Cancer Center in Ho...

HiFiBiO Therapeutics

HiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat disease. The company integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies to discover and accelerate a pipeline of antibody drugs to treat cancer and autoimmune disorders. In addition, HiFiB...

MetaBios Incorporated

MetaBios is a technology company specialized in the development of innovative cell culture, fermentation and bioprocessing products for use in life sciences and biotechnology. We design, manufacture and market disposable bioreactors that offer convenience, capacity and flexibility. Our bioreactor systems include Optima - a unique gas permeable culture bag system for cell culture on laboratory s...

Satori Pharmaceuticals Incorporated

Satori Pharmaceuticals is committed to the development of disease modifying therapies for Alzheimer's disease through innovative approaches that selectively target the key neurotoxic mediators and pathways of this debilitating neurodegenerative disorder.


More From BioPortfolio on "Hemostasis in Sickle Cell Disease--Infancy to Adulthood"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks